RPAP3 inhibitors represent a chemical class designed to target the RPAP3 (RNA Polymerase II-associated Protein 3) component of the R2TP complex, which plays a crucial role in the assembly and stabilization of multi-protein complexes involved in fundamental cellular processes. RPAP3 is essential for the biogenesis of various protein complexes, such as RNA polymerase II, which governs transcriptional regulation in cells. Additionally, RPAP3 is involved in chaperoning proteins for proper folding and maintaining the integrity of molecular machines like the PIKK (Phosphatidylinositol 3-kinase-related kinase) family, influencing DNA damage response pathways, cellular growth, and metabolism. The inhibitors of RPAP3 target this scaffolding function, preventing the appropriate assembly or activity of the protein complexes dependent on RPAP3 for their stability and operation. As a result, these inhibitors are useful tools in studying how RPAP3 and its associated protein interactions impact cell homeostasis and proteostasis.
Structurally, RPAP3 inhibitors typically exhibit specific interactions with the RPAP3 protein domain, blocking its ability to bind with client proteins or cofactors required for the proper function of the R2TP complex. By interfering with these protein-protein interactions, RPAP3 inhibitors can disrupt critical cellular pathways without directly inhibiting enzymatic activity. This makes them valuable in dissecting the mechanisms by which molecular chaperone complexes facilitate the assembly of large, dynamic multi-protein structures. The study of RPAP3 inhibitors also offers insight into how the inhibition of protein-protein interactions can affect diverse cellular functions such as transcriptional control, protein synthesis, and stress response pathways. Through these inhibitors, researchers can explore the fine balance of protein stability and interaction networks critical for maintaining cell structure and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
Inhibits the activity of positive transcription elongation factor b (P-TEFb). Can influence RNA Pol II-mediated transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Directly inhibits RNA polymerase II. Could hinder processes where RPAP3 plays a role. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Cyclin-dependent kinase (CDK) inhibitor. CDKs regulate RNA Pol II phosphorylation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Intercalates DNA, preventing RNA synthesis by RNA polymerases. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Known to repress transcription by RNA polymerase II. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
CDK inhibitor, potentially affecting RNA Pol II phosphorylation. | ||||||
H-7, Dihydrochloride | 108930-17-2 | sc-24009 sc-24009A | 10 mg 50 mg | $80.00 $319.00 | ||
Inhibits multiple kinases, which could indirectly affect RPAP3-associated processes. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Analog of adenosine, can lead to premature termination of RNA synthesis. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
Inhibits splicing of pre-mRNAs, could interfere in processes downstream of RPAP3. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Targets the spliceosome, potentially affecting processes associated with RPAP3. | ||||||